Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
Go back to Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 287.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $287.39 | 52 Week High | $139.79 | |||
| Open | $287.39 | 52 Week Low | $82.07 | |||
| Day High | $287.39 | P/E | 668.35 | |||
| Day Low | $287.39 | EPS | $0.43 | |||
| Volume | 1,273 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 5,803 | |||||
